Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St. Jude AF suppression trial

This article was originally published in The Gray Sheet

Executive Summary

Enrollment has begun for a randomized trial to measure the efficacy of a new atrial fibrillation suppression algorithm in cardiac resynchronization therapy, the St. Paul, Minn. firm announces Nov. 17. Because atrial fibrillation can potentially inhibit delivery of CRT, the study will help St. Jude better understand the benefit of implantable cardioverter defibrillators that include the AF-suppression technology. The algorithm suppresses atrial fibrillation by dynamically overdriving ICD stimulation in response to patient activity...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT022932

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel